Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy

Generic Viagra floods the market. Here’s how Pfizer is reacting

by Dan Gorenstein Jul 13, 2018
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
Christopher Furlong/Getty Images

The Trump administration wants drug companies to lower prices. This is what’s actually happening.

by Dan Gorenstein Jul 5, 2018
Pfizer recently raised the list prices for more than 40 of its prescription medications, including the pain med Lyrica. It’s the second time this year Pfizer has boosted list prices. The increases come at a time of increased public and…

Big Pharma's competition to buy new cancer drugs

by Jed Kim Aug 22, 2016
Pfizer spends $14 billion for a new prostate cancer drug plus others in the pipeline

The only way to stop inversions might be tax reform

by Dan Gorenstein Apr 6, 2016
The Pfizer-Allergan merger is out, but what about inversions across the board?
Pfizer was set to merge with Allergan, but after new inversion rules announced by the Treasury Department, the phama giants decided against merging. 
Spencer Platt/Getty Images

Pfizer abandons $160B Allergan deal

by Marketplace Staff Apr 6, 2016
A change in U.S. tax laws has put a halt to the merger.
The outside of Pfizer's headquarters.
Mario Tama/Getty Images

Health care tax inversions allow double dipping, according to new report

by Dan Gorenstein Mar 17, 2016
Companies sidestep taxes that support Medicare or Medicaid, then sell those programs drugs.
Mergers with foreign-based companies can help some U.S. companies avoid taxes. 
Mario Tama/Getty Images
Weekly Wrap

Weekly Wrap: Black Friday as an economic indicator

by Molly Wood Nov 27, 2015
Let's wrap up this holiday week in business and economic news.

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Pfizer's tax-driven Allergan merger

by Tracey Samuelson Nov 23, 2015
Regulators want to cut down on these deals, but this one is full-speed ahead.

Pfizer and Allergan agree to $160 billion "inversion"

by Kimberly Adams Nov 23, 2015
The deal would create the largest pharmaceutical company in the world.

U.S. corporations park billions overseas

by Mitchell Hartman Aug 26, 2014
Pfizer, Merck, Microsoft, Apple and others store money overseas for tax advantage.